Delta-Fly Pharma
About:
Delta-Fly Pharma is a pharmaceutical company developing innovative cancer treatments through a unique module drug discovery approach
Website: https://www.delta-flypharma.co.jp/
Twitter/X: fly_pharma
Top Investors: SMBC Venture Capital, Mitsubishi UFJ Capital, Mizuho Capital, Nissay Capital, Nippon Venture Capital
Description:
Their company name "Delta-Fly" is derived from "Dragonfly (Tonbo)". Tonbo symbolizes the spirit of "regression" from where it only retreats forward, and is also called "the winning insect."
Total Funding Amount:
1.88B JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Tokushima-shi, Tokushima, Japan
Founded Date:
2010-12-06
Founders:
Atsushi Ejima
Number of Employees:
11-50
Last Funding Date:
2018-03-23
IPO Status:
Public
Industries:
© 2025 bioDAO.ai